5-(戊烷-3-基氧基)-7-氧雜雙環(huán)[4.1.0]庚-3-烯-3-羧酸乙酯
奧司他韋中間體(1S,5R,6S)-5-(1-Ethyl-propoxy)-7-oxa-bicyclo[4.1.0]hept-3-ene-3-carboxylic acid ethyl ester
MFCD08063944
Ethyl 5-(3-pentanyloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate
ETHYL(3R,4S,5S)-4,5-EPOXY-3-(1-ETHYL-PROPOXY)-CYCLOHEX-1-ENE-1-CARBOXYLATE
7-Oxabicyclo[4.1.0]hept-3-ene-3-carboxylic acid,5-(1-ethylpropoxy)-,ethyl ester,(1S,5R,6S)
7-Oxabicyclo[4.1.0]hept-3-ene-3-carboxylic acid, 5-(1-ethylpropoxy)-, ethyl ester, (1S,5R,6S)-
Ethyl (3R,4S,5S)-4,5-Epoxy-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylate
ethyl(3R,4R,5S)-4,5-epoxy-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid
Ethyl (1S,5R,6S)-5-(pentan-3-yloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate
T36 BO EUTJ DOY2&2 FVO2 &&(1S,5R,6S)- Form
[1s-(1a,5b,6a)]-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic acid ethyl ester
Ethyl (1S,5R,6S)-5-(3-pentanyloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate
ETHYL(3R,4S,5S)-4,5-EPOXY-3-(1-ETHYL-PROPOXY)-CYCLOHEX-1-ENE-1-CARBOXYLATE(INTERMEDIATE OF OSELTAMIVIR PHOSPHATE )
7-Oxabicyclo[4.1.0]hept-3-ene-3-carboxylic acid, 5-(1-ethylpropoxy)-, ethyl ester
ethyl (1S,5R,6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate
Ethyl (1S,5R,6S)-5-(pentan-3-yl-oxy)-7-oxa-bicyclo[4.1.0]hept-3-ene-3-carboxylate
EEC epoxide
關(guān)鍵字： 磷酸奧司他韋中間體;磷酸奧斯他韋;醫(yī)藥級;工業(yè)級;磷酸奧司他韋關(guān)鍵中間體;
蘇州健華制藥有限公司是以俄羅斯國家科學(xué)院原秘書長利亞霍夫院士為首席科學(xué)家，聘請俄羅斯國家科學(xué)院的化學(xué)、生物學(xué)、臨床醫(yī)學(xué)、病理毒理學(xué)等專家和國內(nèi)的優(yōu)秀科研人才組成核心研發(fā)團(tuán)隊(duì)，并整合俄羅斯國家科學(xué)院和國內(nèi)優(yōu)秀的科研資源創(chuàng)建。公司借助俄羅斯國家科學(xué)院和蘇州生物產(chǎn)業(yè)園完善的研發(fā)配套平臺，開展創(chuàng)新藥物研究。研究領(lǐng)域涵蓋抗體藥物、多肽藥物、抗體偶聯(lián)藥物、抗病毒藥物、抗菌藥物等等。
我公司本著“務(wù)實(shí)敬業(yè)、合作共贏”的態(tài)度，為客戶提供產(chǎn)品供應(yīng)、技術(shù)開發(fā)等最佳服務(wù)。